Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Atherectomy is a minimally invasive procedure that removes plaque from vessels. devices have been developed to facilitate this technique, to cut the plaque from the artery walls using orbital, rotational, laser, and directional techniques. GlobalData uses proprietary data and analytics to provide a comprehensive report on the atherectomy devices devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights New Zealand Atherectomy Devices Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the atherectomy devices market in New Zealand was Boston Scientific followed by Koninklijke Philips, Cardiovascular Systems, Medtronic, AngioDynamics, Avinger and Becton Dickinson and Co.

Atherectomy is especially valuable in eliminating highly calcified plaque. The Atherectomy procedure may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting. Coronary Atherectomy Devices and Lower Extremity Peripheral Atherectomy Devices are covered under this category. Coronary Atherectomy Devices include Coronary Rotational Atherectomy Devices, Coronary Directional Atherectomy Devices, Coronary Orbital Atherectomy Devices and Coronary Laser Atherectomy Devices. Lower Extremity Peripheral Atherectomy Devices include Peripheral Rotational Atherectomy Devices, Peripheral Directional Atherectomy Devices, Peripheral Orbital Atherectomy Devices and Peripheral Laser Atherectomy Devices.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the atherectomy devices devices market within New Zealand was expected to be over $0.6m in 2022.

For the latest complete market share analysis of atherectomy devices device market in New Zealand, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.